testosterone undecanoate has been researched along with Impotence in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.67) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 18 (60.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Partsernyak, AS; Partsernyak, SA; Proshchai, GA; Zagarskikh, EY | 1 |
| Bang, JK; Choi, J; Hong, JY; Lim, JJ; Park, DS; Song, SH; Won, HJ; Yoon, TK | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Wilkinson, P | 2 |
| Jiang, H; Jiang, T; Li, QL; Peng, JQ; Su, XM; Sun, DC; Wang, FP; Zhang, ZW; Zheng, L | 1 |
| Mehtiyev, T | 1 |
| Huang, CC; Li, GY; Liang, JH; Liang, SK; Meng, ZB; Shen, SL; Song, WR; Wei, GQ; Zhang, X; Zhu, CH | 1 |
| Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Jiang, H; Jiang, T; Li, QL; Sun, DC; Wang, FP; Wang, QF; Zhang, ZW; Zheng, L | 1 |
| Doros, G; Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Zajac, JD | 1 |
| Cho, DY; Kim, JJ; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yeo, JK | 1 |
| Carbone, MD; De Pergola, G; Giagulli, VA; Guastamacchia, E; Licchelli, B; Ramunni, MI; Sabbà, C; Triggiani, V | 1 |
| Cui, K; Li, R; Liu, JH; Rao, K; Wang, SG; Wang, T; Ye, ZQ; Zhang, Y | 1 |
| Almehmadi, Y; Nettleship, JE; Salman, M; Yassin, AA | 1 |
| Gamidov, SI; Mazo, EB; Sotnikova, EM | 1 |
| Frank, MA; Gomzhin, AI; Zhuravlev, VN | 1 |
| Fan, XB; Huang, YF | 1 |
| Ahn, TY; Kim, JJ; Kim, SW; Lee, JY; Lee, SW; Moon, DG; Paick, JS; Park, JK; Park, K; Park, MG; Park, NC; Seo, JT; Yang, DY | 1 |
| Escovar, P; Fraile, C; Garcia, JA; Sanchez, PE | 1 |
| Li, J; Li, WX; Luo, L; Wang, S; Wang, XK | 1 |
| Boneva, Z; Boyanov, MA; Christov, VG | 1 |
| Gontcharov, NP; Kalinchenko, SY; Katsiya, GV; Kozlov, GI | 1 |
| Biagiotti, G; Caracciolo, S; Cavallini, G; Modenini, F; Vitali, G | 1 |
| Saad, F; Yassin, AA | 1 |
| Behre, HM; Gooren, L; Jockenhel, F; Kamischke, A; Nieschlag, E; Saad, F; Schubert, M; Yassin, A; Zitzmann, M | 1 |
| Heaton, JP; Johnston, B; Lundie, M; Morales, A | 1 |
| Baldini, A; Carani, C; Della Casa, L; Ghizzani, A; Marrama, P; Zini, D | 1 |
| Baldini, A; Carani, C; Celani, MF; Della Casa, L; Marrama, P; Zini, D | 1 |
| Bancroft, J; Dickerson, M; Fairburn, CG; Gray, J; Greenwood, J; Stevenson, N; Warner, P | 1 |
4 review(s) available for testosterone undecanoate and Impotence
| Article | Year |
|---|---|
[65-month testosterone replacement therapy for androgen deficiency-induced ED: a case report and review of the literature].
Topics: Androgens; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Male; Middle Aged; Testosterone; Treatment Outcome | 2014 |
[Testosterone undecanoate for late -onset hypogonadism: an update].
Topics: Erectile Dysfunction; Humans; Hypogonadism; Male; Testosterone | 2010 |
Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).
Topics: Aging; Delayed-Action Preparations; Erectile Dysfunction; Humans; Hypogonadism; Male; Testosterone; Testosterone Congeners | 2006 |
More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
Topics: Contraceptive Agents, Male; Erectile Dysfunction; Humans; Hypogonadism; Injections, Intramuscular; Male; Testosterone; Testosterone Congeners | 2007 |
15 trial(s) available for testosterone undecanoate and Impotence
| Article | Year |
|---|---|
[Benefits of androgen replacement therapy and audio-visual correction inclusion in the prevention of premature aging.]
Topics: Aged; Aging, Premature; Androgens; Audiovisual Aids; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Male; Penile Erection; Testosterone | 2020 |
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Topics: Adult; Affect; Aged; Aged, 80 and over; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; England; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Quality of Life; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2013 |
[Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED].
Topics: Adult; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Testosterone; Treatment Outcome | 2013 |
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Topics: Adult; Aged; Androgens; Body Composition; Body Mass Index; Delayed-Action Preparations; Depressive Disorder; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone; Young Adult | 2014 |
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Aging; Androgens; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Placebos; Testosterone; Treatment Outcome | 2014 |
The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome.
Topics: Adult; Aged; Carbolines; Delayed-Action Preparations; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Testosterone | 2015 |
[Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
Topics: Drug Therapy, Combination; Endothelium, Vascular; Erectile Dysfunction; Homocysteine; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Risk Factors; Sulfones; Testosterone; Treatment Outcome; Triazines; Vardenafil Dihydrochloride | 2008 |
The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
Topics: Adult; Aged; Androgens; Cross-Cultural Comparison; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Korea; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2010 |
Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Phosphodiesterase 5 Inhibitors; Testosterone | 2011 |
[Tadalafil improves total testosterone, IIEF score and SEP in old and middle-aged males with late-onset hypogonadism].
Topics: Carbolines; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Sexual Behavior; Tadalafil; Testosterone; Treatment Outcome | 2012 |
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Topics: Androgens; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Erectile Dysfunction; Homeostasis; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Testosterone | 2003 |
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Topics: Aged; Aging; Carnitine; Climacteric; Depression; Drug Therapy, Combination; Erectile Dysfunction; Fatigue; Humans; Male; Middle Aged; Placebos; Prostate; Prostate-Specific Antigen; Testosterone; Testosterone Congeners; Treatment Outcome | 2004 |
Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Hypogonadism; Libido; Male; Methyltestosterone; Middle Aged; Testosterone; Testosterone Congeners | 1997 |
Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Hypogonadism; Luteinizing Hormone; Male; Sexual Behavior; Testosterone | 1990 |
Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
Topics: Adult; Clinical Trials as Topic; Erectile Dysfunction; Humans; Luteinizing Hormone; Male; Testosterone | 1989 |
11 other study(ies) available for testosterone undecanoate and Impotence
| Article | Year |
|---|---|
Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple.
Topics: Adult; Androgens; Azoospermia; Erectile Dysfunction; Humans; Hypogonadism; Infertility, Male; Male; Oligospermia; Testosterone | 2013 |
Long-term testosterone supplementation is useful for ED with testosterone deficiency.
Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone | 2013 |
The use of drugs Impaza and Nebido in the treatment of erectile dysfunction in patients with type 2 diabetes mellitus of reproductive age.
Topics: Adolescent; Adult; Androgens; Antibodies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Penile Erection; Surveys and Questionnaires; Testosterone; Treatment Outcome; Young Adult | 2013 |
Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Personal Satisfaction; Piperazines; Prospective Studies; Sexual Partners; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2014 |
Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Topics: Aged; Androgens; Body Composition; Body Mass Index; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Penile Erection; Prospective Studies; Quality of Life; Testosterone; Triglycerides; Waist Circumference | 2014 |
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypogonadism; Incretins; Liraglutide; Male; Metformin; Middle Aged; Obesity; Penile Erection; Retrospective Studies; Risk Reduction Behavior; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2015 |
[Androgen may improve erectile function in castrated rats by regulating the ERK1/2 pathway].
Topics: Androgens; Animals; Blotting, Western; Erectile Dysfunction; Hormone Replacement Therapy; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitric Oxide Synthase Type III; Orchiectomy; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Testosterone | 2015 |
Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Aging; Androgens; Body Mass Index; Body Weight; Cardiovascular Diseases; Erectile Dysfunction; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Obesity; Prospective Studies; Quality of Life; Reproductive Health; Risk Factors; Surveys and Questionnaires; Testosterone; Waist Circumference; Young Adult | 2017 |
Sexual functions of men with obstructive sleep apnoea syndrome and hypogonadism may improve upon testosterone administration: a pilot study.
Topics: Adult; Continuous Positive Airway Pressure; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Pilot Projects; Piperazines; Sleep Apnea, Obstructive; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2009 |
Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone.
Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Testosterone Congeners; Treatment Failure; Vasodilator Agents | 2003 |
Sex therapy outcome research: a reappraisal of methodology. 1. A treatment study of male sexual dysfunction.
Topics: Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Marital Therapy; Sexual Behavior; Testosterone | 1986 |